Board Director
National Academies of Sciences, Engineering, and Medicine
Washington, District of Columbia, United States
Ann L. Yaktine, Ph.D., M.S., R.D. is Director of the Food and Nutrition Board (FNB) of the National Academies of Sciences, Engineering, and Medicine. In her role as Director, she is responsible for developing, implementing, and managing the board’s activities, as well as engaging FNB members in strategic planning to identify important and emerging issues in nutrition and food sciences, and food safety. Previously she was senior program officer and study director at the National Academies, managing a range of studies, including risks and benefits in seafood choices, safety of genetically engineered foods, front-of-pack food labeling. In 2009 Dr. Yaktine participated in the Korea-U.S. Symposium on the Science of Food Safety Assessment. Prior to joining the National Academies, she worked as a clinical dietitian and WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) program director, instructor and dietetics internship site supervisor at Virginia Polytechnic Institute and State University, and instructor in the Department of Nutrition and Food Science at the University of Nebraska – Lincoln. She has published journal reports on nutrition and cancer, nutrients and contaminants in foods, and nutrition assistance programs. Dr. Yaktine is a member of the Academy of Nutrition and Dietetics and the American Society for Nutrition. She holds an M.S. in nutrition from the University of Kansas and a Ph.D. in biochemistry and a certificate in cancer biology from the Eppley Institute for Research in Cancer and Allied Diseases at the University of Nebraska Medical Center.
Update from the NASEM Food and Nutrition Board
Tuesday, July 2, 2024
8:30 AM – 9:30 AM CT
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Welcome and Introductions - Update from the NASEM Food and Nutrition Board
Tuesday, July 2, 2024
8:30 AM – 8:40 AM CT
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.